Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
711 (USA) · Dr. Jansen
consented 2012-07-29
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild EAR INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-04 (study day 7.0); relationship: NONE
mild
assessed
Mild EAR INFECTION — outcome: RECOVERED/RESOLVED; onset 2012-08-04 (study day 7.0); relationship: NONE
mild
assessed
Mild GLOSSITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-12 (study day 15.0); relationship: NONE
mild
assessed
Mild HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-07-29 (study day 1.0); relationship: NONE
Data queries
No data queries.